The rapid evolution of technology in healthcare has led to increased interest in artificial intelligence (AI) and machine learning (ML), especially in revenue cycle management (RCM). These advancements aim to improve efficiency and reduce errors while automating traditional processes. As organizations manage these changes, it is essential for medical practice administrators, owners, and IT managers to ask the right questions when evaluating AI and ML vendors. This article outlines essential inquiries to ensure informed decision-making for AI-driven revenue cycle solutions.
Organizations should first understand the roles of AI and ML in RCM. AI includes various technologies, while ML refers specifically to algorithms that learn and improve from data over time. Together, they streamline manual processes such as eligibility checks, prior authorization submissions, and claims follow-ups.
Medical practices in the United States recognize the role of ML in addressing common RCM challenges. For example, Amy Raymond, VP of Revenue Cycle Operations at AKASA, notes that one major reason for implementing machine learning is to simplify the complexities of eligibility verification related to insurance cards. Automation allows medical organizations to handle eligibility checks efficiently, reducing the delays that often occur during patient registrations and follow-ups.
As healthcare organizations assess AI and ML vendors, they should consider the following questions:
Understanding a vendor’s expertise in RCM is important. Organizations should think about whether the vendor has experience in healthcare revenue cycle solutions. Asking about experience dealing with complex revenue cycle challenges can provide insight into their ability to deliver effective solutions.
Organizations should also check if the vendor understands the details of RCM, such as eligibility checks, prior authorizations, and denials management. Amy Raymond states that effective application of machine learning in RCM requires vendors with domain-specific knowledge.
Requesting case studies or examples of successful AI and ML implementations in RCM can reveal their potential effectiveness. This inquiry allows healthcare organizations to understand the benefits, such as reduced denials and better workflows. A documented success story lends credibility to the vendor’s claims.
Given the sensitivity of patient data, compliance with HIPAA and HiTrust regulations is essential for any AI/ML vendor. Medical practices should inquire about the vendor’s commitment to high-security standards for data management. Solutions built on platforms like Amazon Web Services (AWS) enhance compliance efforts and prioritize data protection.
AI and ML solutions rely on continuous learning and adaptability. Organizations should ask how the vendor’s system evolves with new data or changing circumstances. Robotic Process Automation (RPA) can execute routine tasks but lacks adaptability in new scenarios. In contrast, ML aids decision-making by analyzing past patterns and outcomes.
While AI can boost efficiency, human oversight remains essential. This safeguard ensures that biases are recognized and outlier data is flagged for review. Verun Ganapathi, CTO of AKASA, highlights the importance of human involvement in identifying potential errors in AI learning processes. Organizations need to ask about the vendor’s integration of human oversight into their AI systems.
Understanding how a vendor handles errors in ML applications is crucial. Human oversight is useful for catching issues, but organizations should also check whether the AI solution learns from various scenarios and corrections. A comprehensive error management strategy is vital for ongoing improvement of the AI system.
Integrating AI and ML solutions into existing workflows is critical for maximizing effectiveness. Organizations should assess how the vendor’s solutions fit into their current RCM processes. This alignment ensures that AI deployment does not disrupt daily operations but enhances them. Vendors must demonstrate an understanding of the organization’s specific workflow needs and provide tailored solutions.
It is useful to inquire about the specific AI and ML technologies used by vendors. With many methodologies available, understanding the technologies behind their solutions can help organizations determine suitability for addressing unique RCM challenges. Additionally, organizations might want to evaluate whether the vendor uses proprietary technologies or relies on third-party tools.
Scalability is an important consideration when evaluating AI and ML vendors, especially for healthcare organizations anticipating growth or changes. ML solutions usually offer better scalability than RPA, as they require less ongoing support for rule adjustments. This feature is significant for accommodating future expansions or shifts in focus.
Vendors should outline the metrics and key performance indicators used to measure the success of their AI and ML implementations. Important measures include reductions in claim denials, improved authorization turnaround times, and increased patient satisfaction scores. Understanding a vendor’s approach to measuring success provides assurance of their results-oriented focus.
As organizations evaluate AI and ML solutions, they should focus on areas ripe for automation within their workflow. Efficient RCM depends on several key processes that often require manual labor:
Incorporating AI and ML into revenue cycle management can lead to increased efficiency, fewer errors, and better patient experiences. As the industry continues to change, it is crucial for medical practice administrators, owners, and IT managers to ask the right questions to ensure optimal vendor selection. The realm of RCM is constantly evolving, driven by technological advances and shifting healthcare demands. By understanding these key factors, organizations can make informed decisions that improve their workflows and contribute to the sustainability of their healthcare practices.
ML can automate and optimize processes within RCM by improving tasks like eligibility checks, prior authorizations, claims follow-ups, and denials management, leading to increased efficiency and reduced errors.
The revenue cycle has progressed from a manual stage, using basic tools like spreadsheets, to automation through robotic process automation (RPA), and is now transitioning toward integrated machine learning solutions that enhance decision-making and processing.
RPA is rule-based and suitable for simple tasks requiring specific inputs, while ML can adapt and learn from data, enabling it to handle more complex tasks and exceptions without constant reprogramming.
Unified Automation combines AI and ML with human expertise in RCM to automate processes intelligently. It allows the system to learn from human input while ensuring quality control on exceptions.
Key areas include automating eligibility checks from insurance cards, streamlining prior authorization processes, enhancing responses to no-response claims, and improving denials management through better understanding of payer requirements.
AKASA employs human oversight to catch systemic errors and flags outlier data for expert review, allowing the AI to continuously learn and improve from diverse scenarios and corrections.
Organizations should inquire about the vendor’s expertise, specific experience in RCM, research contributions, proprietary technologies, and whether they rely on third-party tools to meet healthcare needs.
ML solutions are more scalable than RPA because they require less ongoing technical support for rule updates and can handle a wider range of tasks, adapting to complex processes as they evolve.
Building on AWS provides built-in security, compliance with HIPAA and HiTrust regulations, and high availability, which are essential for healthcare organizations managing sensitive data.
Having a human in the loop provides a safeguard against potential errors, ensures nuanced understanding in decision-making, and enhances the AI’s learning process by correcting biases or outliers in real-time.